ET Newsmakers 2021, East,is an initiative for organisations, brands, and individuals engaged in business activities and have been able to c...

The company is in talks with strategic investors to help it expand sales of its fertility-related product and solutions to India and South ...

Dr Reddy claimed that Goldman and NEA, which together hold 52% shares, ignored higher offers from TPG Capital and VPS Healthcare of Middle ...

India has the potential to become a leading global player for stem cell products and services. So, the government must act fast in implemen...

Short-stay surgery provider Nova Specialty Surgery has raised 300 crore from Goldman Sachs and existing investor New Enterprise Associates,...

Nova Specialty Surgery has raised Rs 300 cr from Goldman Sachs & existing investor NEA, to expand its network of centers and fertility clin...

Nova Medical Centres today said it has formed a joint venture with Spanish reproductive medicine firm, IVI with plans to set up 25 clinics ...

Forget multi-speciality hospitals. Niche is where patients are heading. Growing awareness and the emergence of a new breed of entrepreneurs...

A European healthcare chain is close to acquiring a 15% strategic stake in day-care hospital chain Nova Medical’s In Vitro Fertilisation.

"The two interested parties are global leaders in the IVF segment," Nova Medical chairman Suresh Soni said.

At least over a dozen institutions are publicly undertaking some activity or the other in the field of stem cells in India while it is reas...

The government proposes to regulate stem cell sourcing, banking, transfer (exports) and research.